Evidence map›Paper›PMID 24705369›Full record

ArticlePloS one2014

Sorting nexin 17 regulates ApoER2 recycling and reelin signaling.

Pablo Sotelo, Pamela Farfán, María Luisa Benitez, Guojun Bu, María-Paz Marzolo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Drospondin, a glial glycoprotein with similarities to human Reelin/F-spondin, contributes toProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. The Role of Sorting Nexin 17 in Cardiac Development.Frontiers in cardiovascular medicine · 2021
    Article
  16. The emerging role of sorting nexins in cardiovascular diseases.Clinical science (London, England : 1979) · 2019
    Review
  17. Article
  18. The Reelin Receptors Apolipoprotein E receptor 2 (ApoER2) and VLDL Receptor.International journal of molecular sciences · 2018
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Pablo SoteloDepartamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Millenium Nucleus for Renerative Biology (MINREB), Pontificia Universidad Católica de Chile, Santiago, Chile.
Pamela FarfánDepartamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Millenium Nucleus for Renerative Biology (MINREB), Pontificia Universidad Católica de Chile, Santiago, Chile.
María Luisa BenitezDepartamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Millenium Nucleus for Renerative Biology (MINREB), Pontificia Universidad Católica de Chile, Santiago, Chile.
Guojun BuDepartment of Neuroscience, Mayo Clinic, Jacksonville, Florida, United States of America.
María-Paz MarzoloDepartamento de Biología Celular y Molecular, Facultad de Ciencias Biológicas, Millenium Nucleus for Renerative Biology (MINREB), Pontificia Universidad Católica de Chile, Santiago, Chile.
Pontificia Universidad Católica de Chile · CLMayo Clinic in Florida · US

Funding

TRANSGENIC MOUSE COREP01AG030128 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI WEEBER, EDWIN JOHN · 2009 to 2013
$9.4M
ApoE Receptor Pathways to Intraneuronal AbetaR01AG027924 · NIA · WASHINGTON UNIVERSITY · PI LI, YONGHE · 2006 to 2021
$3.7M
NIA NIH HHS P01 AG030128NIA NIH HHS R01 AG027924
6 · The paper itself

Abstract

ApoER2 is a member of the low density-lipoprotein receptor (LDL-R) family. As a receptor for reelin, ApoER2 participates in neuronal migration during development as well as synaptic plasticity and survival in the adult brain. A previous yeast two-hybrid screen showed that ApoER2 is a binding partner of sorting nexin 17 (SNX17) - a cytosolic adaptor protein that regulates the trafficking of several membrane proteins in the endosomal pathway, including LRP1, P-selectin and integrins. However, no further studies have been performed to investigate the role of SNX17 in ApoER2 trafficking and function. In this study, we present evidence based on GST pull-down and inmunoprecipitation assays that the cytoplasmic NPxY endocytosis motif of ApoER2 interacts with the FERM domain of SNX17. SNX17 stimulates ApoER2 recycling in different cell lines including neurons without affecting its endocytic rate and also facilitates the transport of ApoER2 from the early endosomes to the recycling endosomes. The reduction of SNX17 was associated with accumulation of an ApoER2 carboxy-terminal fragment (CTF). In addition, in SNX17 knockdown cells, constitutive ApoER2 degradation was not modified, whereas reelin-induced ApoER2 degradation was increased, implying that SNX17 is a regulator of the receptor's half-life. Finally, in SNX17 silenced hippocampal and cortical neurons, we underscored a positive role of this endosomal protein in the development of the dendritic tree and reelin signaling. Overall, these results establish the role of SNX17 in ApoER2 trafficking and function and aid in identifying new links between endocytic trafficking and receptor signaling.

Indexed as

Amyloid Precursor Protein SecretasesAnimalsCell Adhesion Molecules, NeuronalEscherichia coliExtracellular Matrix ProteinsFlow CytometryHEK293 CellsHeLa CellsHumansImmunoprecipitationLDL-Receptor Related ProteinsLentivirusNerve Tissue ProteinsNeuronsRatsReelin ProteinAmyloid Precursor Protein SecretasesCell Adhesion Molecules, NeuronalExtracellular Matrix ProteinsLDL-Receptor Related Proteinslow density lipoprotein receptor-related protein 8Nerve Tissue ProteinsReelin ProteinRELN protein, humanReln protein, ratSerine EndopeptidasesSNX17 protein, humanSorting Nexins

Identifiers

PMID24705369
PMCPMC3976305
OpenAlexW2052410153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.